PANCREATIC DUCTAL CARCINOMA
Clinical trials for PANCREATIC DUCTAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC DUCTAL CARCINOMA trials appear
Sign up with your email to follow new studies for PANCREATIC DUCTAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer pill enters human testing for Tough-to-Treat tumors
Disease control CompletedThis first-in-human study tested a new oral drug called JAB-3312 in 40 adults with advanced solid tumors that had progressed despite standard treatments. The main goals were to find the safest dose and see how the body processes the drug. Researchers also looked for early signs t…
Matched conditions: PANCREATIC DUCTAL CARCINOMA
Phase: PHASE1 • Sponsor: Jacobio Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New Two-Drug attack on tough cancers shows early promise
Disease control CompletedThis early-stage study tested the safety of combining two experimental drugs, vobramitamab duocarmazine and lorigerlimab, in people with advanced solid tumors that had stopped responding to standard treatments. The main goal was to find a safe dose and see how the body processes …
Matched conditions: PANCREATIC DUCTAL CARCINOMA
Phase: PHASE1 • Sponsor: MacroGenics • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC